Research Interests
    The primary focus of the Montelaro lab is to elucidate the intricate interactions between viral pathogens and host immune responses to determine the mechanisms by with host immunity contributes to protection and disease and to serve as a basis for the development of effective vaccines.

    A particular interest of the lab is to develop effective strategies to overcome the challenge of natural viral antigenic variation that has evolved as a common complication to the development of effective vaccines to important viral diseases, including those related to biodefense and emerging infectious diseases. Systems currently under investigation include HIV-1 and related animal lentiviruses (SHIV, SIV, and EIAV), dengue virus, and influenza virus. Studies in these systems include investigation of the nature and role of antigenic variation during infection, the development of novel assays to characterize virus-specific innate, humoral, and cellular immune responses, and the design of engineered immunogens for effective vaccination against variant strains of a particular virus.

    In addition to these vaccine related studies, the lab also maintains a research program to develop novel de novo antimicrobial peptides (engineered cationic amphipathic peptides, or eCAPs) that can be used to inactivate a diverse spectrum of bacteria or enveloped viruses in a prophylactic or therapeutic treatment modalities.


 
Selected Publications
  1. Sun, C., Zhang, B., Jin, J., and Montelaro, R. (2008) Equine infectious anemia virus binding to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein. J. Gen. Virol. 89: 2010-2018.

  2. Yang, W., Qiu, C., Biswas, N., Jin, J., Watkins, S., Montelaro, R., Coyne, C., and Wang, T. (2008) Correlation of tight junction-like distribution of claudin-1 to the cellular tropism of HCV. J. Biol. Chem. 283: 8643-8653.

  3. Pawar, S., Mattila, J., Sturgeon, T., Lin, P., Narayan, O., Montelaro, R., and Flynn, J. (2008) Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV89.6P and SHIV-Ku2 in cynomolgus macaques. AIDS Res. Human Retroviruses 24: 643-654.

  4. Tagmyer, T., Craigo, J., Cook, S., Issel, C., and Montelaro, R. (2008) Envelope peptide determinants of vaccine protection and the effects of sequence variation on immune recognition. J. Virol. 82:4052-4063.

  5. Zhang, B., Sun, C., Cascio, M., Montelaro, R. (2008) Mapping of equine lentivirus receptor-1 residues critical for EIAV envelope binding. J. Virol. 82: 1204-1213.

    Complete Publication Listing
 
Grant Support
  1. Title: EIAV envelope variation and vaccine efficacy
    Agency: NIH/NIAID
    Role: Principal Investigator
    Funding Period: 2003-2008

  2. Title: Cellular and molecular biology of EIAV replication
    Agency: NIH
    Role: Principal Investigator
    Funding Period: 2007-2009

  3. Title: Evaluation of the intracytoplasmic domain of HIV-1 gp41 as a vaccine immunogen
    Agency: NIH/NIAID
    Role: Principal Investigator
    Funding Period: 2006– 2009

  4. Title: Dengue virus like particle vaccine
    Agency: DoD/USAMRMC
    Role: Co-investigator
    Funding Period: 2007–2011

  5. Title: Dengue envelope domain III-C3d vaccine
    Agency: DoD/USAMRMC
    Role: Co-investigator
    Funding Period: 2007-2010
 
Other Links
Department of Microbiology and Molecular Genetics
Montelaro Laboratory
Center for Vaccine Research
University of Pittsburgh
 
   
     
  Ronald C. Montelaro, Ph.D.
Office:  9016 BST3
Lab:9053 BST3
Phone:412-648-8869
Fax: 412-624-4440
rmont@pitt.edu
 
Academic Affiliations
  • Professor of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine

  • Professor of Infectious Diseases and Immunology, University of Pittsburgh Graduate School of Public Health

  • Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine


  • Co-Director, Center for Vaccine Research, University of Pittsburgh

  • Co-Director, Pittsburgh Center for HIV-1 Protein Interactions, University of Pittsburgh

  • Director, Peptide Synthesis Core, University of Pittsburgh

  • Member, University of Pittsburgh Cancer Institute

 
Education
  • B.S., Biochemistry, Louisiana State University-Baton Rouge, 1971

  • Ph.D., Biochemistry, University of Wisconsin-Madison, 1975

  • Postdoc, Retrovirology, Duke University Medical Center, 1976-1979

 
Lab Personnel

Research Assistant Professor
Jodi Craigo, Ph.D.

Research Instructor
Baoshan Zhang, Ph.D.

Graduate Student
Jonathan Steckbeck, M.B.A., B.S.

Research Specialists
Shannon Barnes, M.S.
Tim Sturgeon, B.S.